Shares of telehealth services provider Hims & Hers (NYSE:HIMS) fell 22% Thursday after Amazon (NASDAQ:AMZN) announced it was entering the hair loss and erectile dysfunction treatment markets ...

Hims & Hers Health on Monday announced Nader Kabbani, a former Amazon executive who helped establish many of its health-care offerings, will join the telehealth company as its chief operations ...

Shares of Hims & Hers (HIMS) are sliding on Thursday after Amazon (AMZN) announced the launch of its Amazon One Medical Pay-per-visit telehealth service, which Citi believes is "very similar" to ...

Analysts at Bank of America downgraded shares of Hims & Hers from buy to underperform on Thursday, citing Amazon's push into hair loss and erectile dysfunction markets. The analysts said Hims ...

BofA downgraded Hims & Hers (HIMS) to Underperform from Buy with a price target of $18, down from $32. Amazon (AMZN) launched a cash-pay telehealth service and treatment offering that could ...

Amazon’s One Medical telehealth service is adding a new option that will put it in direct competition with Hims & Hers. That sent HIMS down from over $30 to a low of $19.15 last Friday.

Hims & Hers (HIMS) fell 22% after Amazon (AMZN) announced it was entering the hair loss and erectile dysfunction treatment markets through its telehealth unit. Read more here.

The analysts said Hims & Hers generates more than 80% gross margins from its core erectile dysfunction and hair loss offerings, and estimate that Amazon's medications for those conditions are ...